ArticleClinical and translational allergy2015

An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial.

A M Chaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.